Phibro Animal Health (NASDAQ:PAHC) Releases Earnings Results, Beats Expectations By $0.14 EPS

Phibro Animal Health (NASDAQ:PAHC) released its earnings results on Wednesday. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14, Zacks reports. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%.

Phibro Animal Health Stock Up 1.6 %

Shares of NASDAQ:PAHC traded up $0.35 during midday trading on Wednesday, hitting $22.37. The stock had a trading volume of 148,908 shares, compared to its average volume of 141,028. The company has a market cap of $905.99 million, a P/E ratio of 52.02, a PEG ratio of 0.56 and a beta of 0.52. Phibro Animal Health has a 12 month low of $10.03 and a 12 month high of $25.98. The business’s 50-day simple moving average is $21.89 and its 200-day simple moving average is $21.60. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.15%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Analyst Ratings Changes

PAHC has been the subject of a number of research reports. Barclays raised their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. Morgan Stanley upped their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, January 29th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.